1. Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy.
- Author
-
Spungen HH, Mody K, Micetic B, Wade C, and Kang AM
- Subjects
- Humans, Female, Pregnancy, Adult, Infant, Newborn, Male, Pregnancy Complications drug therapy, Neonatal Abstinence Syndrome diagnosis, Neonatal Abstinence Syndrome drug therapy, Prenatal Exposure Delayed Effects chemically induced, Kava adverse effects
- Abstract
Introduction: Kava, a substance derived from the Piper methysticum plant, is enjoying a surge in popularity in the United States due to its purported anxiolytic and analgesic effects. Though ichthyosiform dermopathy is a known adverse effect associated with chronic kava exposure in adults, dermopathy in a newborn due to maternal kava use has not yet been described., Case Report: This is a case of a 41-year-old woman who was taking a combination kava/kratom product throughout her pregnancy. She developed an ichthyosiform dermopathy that resolved after she stopped using the product postpartum. Her male infant had a neonatal course complicated by both neonatal opioid withdrawal syndrome, attributed to maternal kratom and buprenorphine use, as well as a diffuse ichthyosiform rash similar to descriptions of kava ichthyosiform dermopathy in adults. His neonatal course was complicated by Group B streptococcus and Serratia marscecens bacteremia (treated with antibiotics) and seizures (treated with lorazepam and phenobarbital). His rash resolved completely by day of life 22. At 9-month outpatient follow-up, he had no dermatologic abnormalities or rash recurrence., Discussion: Maternal kava use during pregnancy may cause fetal dermopathy presenting as an acquired ichthyosis. More public education is needed about the potential consequences of kava use, particularly during pregnancy., (© 2024. American College of Medical Toxicology.)
- Published
- 2024
- Full Text
- View/download PDF